Literature DB >> 7716713

Immunological intervention reveals reciprocal roles for tumor necrosis factor-alpha and interleukin-10 in rheumatoid arthritis and systemic lupus erythematosus.

R N Maini1, M J Elliott, P J Charles, M Feldmann.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 7716713     DOI： 10.1007/bf00197526

Source DB:  PubMed          Journal:  Springer Semin Immunopathol        ISSN： 0344-4325


× No keyword cloud information.
  30 in total

1.  Low levels of interleukin-4 and high levels of transforming growth factor beta in rheumatoid synovitis.

Authors:  P Miossec; M Naviliat; A Dupuy d'Angeac; J Sany; J Banchereau
Journal:  Arthritis Rheum       Date:  1990-08

2.  Detection of interleukin 8 biological activity in synovial fluids from patients with rheumatoid arthritis and production of interleukin 8 mRNA by isolated synovial cells.

Authors:  F M Brennan; C O Zachariae; D Chantry; C G Larsen; M Turner; R N Maini; K Matsushima; M Feldmann
Journal:  Eur J Immunol       Date:  1990-09       Impact factor: 5.532

3.  Tumor necrosis factor and IL-1 in New Zealand Black/White mice. Enhanced gene expression and acceleration of renal injury.

Authors:  D C Brennan; M A Yui; R P Wuthrich; V E Kelley
Journal:  J Immunol       Date:  1989-12-01       Impact factor: 5.422

Review 4.  The biology of cachectin/TNF--a primary mediator of the host response.

Authors:  B Beutler; A Cerami
Journal:  Annu Rev Immunol       Date:  1989       Impact factor: 28.527

5.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis.

Authors:  R O Williams; M Feldmann; R N Maini
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

6.  Expression of granulocyte-macrophage colony-stimulating factor in rheumatoid arthritis: regulation by tumor necrosis factor-alpha.

Authors:  C Haworth; F M Brennan; D Chantry; M Turner; R N Maini; M Feldmann
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

7.  Tumour necrosis factor-alpha in murine autoimmune 'lupus' nephritis.

Authors:  C O Jacob; H O McDevitt
Journal:  Nature       Date:  1988-01-28       Impact factor: 49.962

8.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs.

Authors:  G S Panayi; P Wooley; J R Batchelor
Journal:  Br Med J       Date:  1978-11-11

9.  Treatment of (NZB x NZW)F1 disease with anti-I-A monoclonal antibodies.

Authors:  N E Adelman; D L Watling; H O McDevitt
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

10.  Cachectin/tumor necrosis factor stimulates collagenase and prostaglandin E2 production by human synovial cells and dermal fibroblasts.

Authors:  J M Dayer; B Beutler; A Cerami
Journal:  J Exp Med       Date:  1985-12-01       Impact factor: 14.307
View more
  10 in total

Review 1.  Access to disease modifying treatments for rheumatoid arthritis patients.

Authors:  D E Furst; F C Breedveld; G R Burmester; L Crofford; P Emery; M Feldman; J R Kalden; A Kavanaugh; E Keystone; P E Lipsky; R N Maini; L Moreland; J S Smolen; L Van De Putte; T Vischer; M Weinblatt; M Weissman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Sympathetic modulation of immunity: relevance to disease.

Authors:  Denise L Bellinger; Brooke A Millar; Sam Perez; Jeff Carter; Carlo Wood; Srinivasan ThyagaRajan; Christine Molinaro; Cheri Lubahn; Dianne Lorton
Journal:  Cell Immunol       Date:  2008-03-04       Impact factor: 4.868

3.  Biological insights from clinical trials with anti-TNF therapy.

Authors:  M Feldmann; P Charles; P Taylor; R N Maini
Journal:  Springer Semin Immunopathol       Date:  1998

4.  Polymorphism of interleukin-10 promoter and tumor necrosis factor receptor II in Vietnamese patients with systemic lupus erythematosus.

Authors:  Pham Dang Khoa; Tsuyoshi Sugiyama; Takashi Yokochi
Journal:  Clin Rheumatol       Date:  2004-07-07       Impact factor: 2.980

5.  IL-1β (Interleukin-1β) and TNF-α (Tumor Necrosis Factor-α) Impact Abdominal Aortic Aneurysm Formation by Differential Effects on Macrophage Polarization.

Authors:  Rishi Batra; Melissa K Suh; Jeffrey S Carson; Matthew A Dale; Trevor M Meisinger; Matthew Fitzgerald; Patrick J Opperman; Jiangtao Luo; Iraklis I Pipinos; Wanfen Xiong; B Timothy Baxter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-12-07       Impact factor: 8.311

Review 6.  Drug-induced lupus.

Authors:  E J Price; P J Venables
Journal:  Drug Saf       Date:  1995-04       Impact factor: 5.606

Review 7.  Beneficial effects of tumour necrosis factor-alpha (TNF-alpha) blockade in rheumatoid arthritis (RA)

Authors:  R N Maini; M J Elliott; F M Brennan; M Feldmann
Journal:  Clin Exp Immunol       Date:  1995-08       Impact factor: 4.330

Review 8.  Environmentally induced autoimmune diseases: potential mechanisms.

Authors:  T Rao; B Richardson
Journal:  Environ Health Perspect       Date:  1999-10       Impact factor: 9.031

9.  Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment.

Authors:  Lisa Gm van Baarsen; Carla A Wijbrandts; François Rustenburg; Tineke Cantaert; Tineke Ctm van der Pouw Kraan; Dominique L Baeten; Ben Ac Dijkmans; Paul P Tak; Cornelis L Verweij
Journal:  Arthritis Res Ther       Date:  2010-01-22       Impact factor: 5.156

10.  Tumour necrosis factor alpha (TNF-alpha), interleukin-6 (IL-6) and their soluble receptors (sTNF-alpha-Rp55 and slL-6R) serum levels in systemic lupus erythematodes.

Authors:  E Robak; A Sysa-Jedrzejowska; T Robak; H Stepień; A Woźniacka; E Waszczykowsk
Journal:  Mediators Inflamm       Date:  1996       Impact factor: 4.711
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.